Nephrocare Health Services Ltd. (NHSL), founded on December 18, 2009, provides end-to-end dialysis care through its extensive clinic network. Its offerings include diagnosis, treatment, and wellness programs, covering hemodialysis, home and mobile dialysis, and pharmacy support. As the largest provider in its segment, NHSL operates 519 clinics worldwide, including 51 international locations across the Philippines (41), Uzbekistan (4), and Nepal (6). In 2024, the global dialysis services market was estimated at ~USD 75.2 billion and is expected to grow to around USD 106.2 billion by 2029, indicating a compound annual growth rate (CAGR) of 7.1% over FY24–FY29 (Source: F&S Report).
Valuation and OutlookThe company aims to strengthen its presence by launching new clinics, partnering with hospitals for asset-light growth, and improving accessibility in underserved regions. Therefore, we recommend a SUBSCRIBE rating for investors with a long-term horizon.
For all IPO report, click hereDisclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Nephrocare Health Services - 101225 - geoDiscover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
